Showing 3631-3640 of 5693 results for "".
- Opthea Publishes Phase 2b Trial Data for Wet AMDhttps://modernod.com/news/opthea-publishes-promising-phase-2b-trial-data-for-wet-amd/2482685/Opthea announced new data from the phase 2b clinical trial using sozinibercept to treat wet age-related macular degeneration (AMD). The results were published in the peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging (OSLI) Retina. Opthea’s complete phase 3 wet AMD
- Altris AI Launches Advanced Optic Disc Analysis for Glaucomahttps://modernod.com/news/altris-ai-launches-advanced-optic-disc-analysis-for-glaucoma-complementing-gcc-asymmetry-analysis/2482683/Altris AI, a provider of AI OCT scan analysis for the detection of a range of retina pathologies and biomarkers, announced the launch of an advanced glaucoma 'Optic Disc Analysis' module. To address need to improve timely and accurate gl
- Glaukos Announces FDA Acceptance of NDA Submission for Epioxahttps://modernod.com/news/glaukos-announces-fda-acceptance-of-nda-submission-for-epioxa/2482677/Glaukos announced it has received notification from the FDA acknowledging the previously submitted new drug application (NDA) for Epioxa (Epi-on), its next-generation corneal cross-linking iLink therapy for the treatment of keratoconus. The FDA stated that the NDA is sufficien
- New Study Uncovers How Genes Influence Retinal Aging and Brain Healthhttps://modernod.com/news/new-study-uncovers-how-genes-influence-retinal-aging-and-brain-health/2482676/New research from the nonprofit biomedical research institution, The Jackson Laboratory (JAX), reveals that genetics play a key role in how the eye ages, with different genetic backgrounds influencing retinal aging in distinct ways. The study, published in
- World’s First AI-Powered Cardiovascular Retinal Screening to be Launched in the UKhttps://modernod.com/news/worlds-first-ai-powered-cardiovascular-retinal-screening-to-be-launched-in-the-uk/2482674/Heart Eye has unveiled AI-powered cardiovascular screening technology using retinal imaging in the UK. The company says the technology delivers patients’ cardiovascular disease risk results in just 3 minutes. The technology, called '
- MyEyeDr. Partners with CoFi to Streamline Patient Paymentshttps://modernod.com/news/myeyedr-partners-with-cofi-to-streamline-patient-payments/2482673/MyEyeDr., which has 880 locations across the US, has teamed up with multi-party payment provider CoFi to simplify the payment process for patients requiring both optometry and ophthalmology services. This new partnership, now available in all 29 states where MyEyeDr. o
- Seonix Bio Launches SightScore, the First Clinical Polygenic Risk Score Test for Glaucoma in the UShttps://modernod.com/news/seonix-bio-launches-sightscore-the-first-clinical-polygenic-risk-score-test-for-glaucoma-in-the-us/2482672/Seonix Bio announced the US launch of SightScore, which the company descibes as the first commercially available clinical polygenic risk score testing service for primary open-angle glaucoma. Already available in Australia and New Zealand, SightScore utilizes
- Cost, Purchase Factors, and Correct Usage Drive Online Contact Lens Searcheshttps://modernod.com/news/cost-purchase-factors-and-correct-usage-drive-online-contact-lens-searches-according-to-new-research-in-the-us-and-canada/2482671/New research from the Contact Lens Institute (CLI) demonstrates that purchase factors–specificly contact lens retailers and price–are the primary driver of consumer online contact lens-related searches, representing 65% of top 20 searches in the United States and Canada. Oth
- Oculus Launches Myopia Software Package on the Pentacam AXL Wavehttps://modernod.com/news/oculus-launches-myopia-software-package-on-the-pentacam-axl-wave/2482670/Oculus is launching the Myopia Software Package on the Pentacam AXL Wave. The new software is designed to offer optometrists improved accuracy, ease, and safety in their myopia management, comprehensive screening, and ortho-k fitting with one device. The Pentacam AXL
- Alcon Announces US Launch of Voyager DSLT for Glaucoma and Ocular Hypertensionhttps://modernod.com/news/alcon-announces-us-launch-of-voyager-dslt-for-glaucoma-and-ocular-hypertension/2482669/Alcon announced the full US commercial availability of Voyager DSLT, the first and only direct selective laser trabeculoplasty device (DSLT). According to Alcon, Voyager DSLT may accelerate the adoption of laser as a first-line therapy, making the treatment availabil